Differential effects of oral vs transdermal ERT on CRP in postmenopausal
Hate to rely all my sad stories, but I had a woman in this week; 60 years old, multiple open heart surgeries, stent placement in both renal arteries and 3 strokes. You would think her cardiologists (a long stream of them) would at some point have discussed insulin management, homocysteine and CRP with her. Appearantly not. She is also currently on oral ERT which, as we see in this study raises CRP levels.
Cardiosource